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Methylphenidate (MPD) is a commonly administered drug to treat children suffering from
attention deficit hyperactivity disorder (ADHD). Alterations in septal driven hippocampal
theta rhythm may underlie attention deficits observed in these patients. Amongst
others, the septo-hippocampal connections have long been acknowledged to be
important in preserving hippocampal function. Thus, we wanted to ascertain if MPD
administration, which improves attention in patients, could affect septal areas connecting
with hippocampus. We used low and orally administered MPD doses (1.3, 2.7 and
5 mg/Kg) to rats what mimics the dosage range in humans. In our model, we observed
no effect when using 1.3 mg/Kg MPD; whereas 2.7 and 5 mg/Kg induced a significant
increase in c-fos expression specifically in the medial septum (MS), an area intimately
connected to the hippocampus. We analyzed dopaminergic areas such as nucleus
accumbens and striatum, and found that only 5 mg/Kg induced c-fos levels increase. In
these areas tyrosine hydroxylase correlated well with c-fos staining, whereas in the MS
the sparse tyrosine hydroxylase fibers did not overlap with c-fos positive neurons. Double
immunofluorescence of c-fos with neuronal markers in the septal area revealed that co-
localization with choline acethyl transferase, parvalbumin, and calbindin with c-fos did
not change with MPD treatment; whereas, calretinin and c-fos double labeled neurons
increased after MPD administration. Altogether, these results suggest that low and acute
doses of methylphenidate primary target specific populations of caltretinin medial septal
neurons.
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Introduction
Attention deficit hyperactivity disorder (ADHD) is a developmental disorder affecting an
estimate of 3--5% of children worldwide. In the 60--80% of cases, symptoms persist into
adolescence and adulthood (Polanczyk et al., 2007). The aetiology of this disorder is not fully
understood, but current belief points to alterations in the dopaminergic system underling the
onset of the disease. For instance, mutations and polymorphisms in the dopamine transporter
(DAT) have been associated with ADHD (Miller and Madras, 2002). Other studies show
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an increase in DAT density up to 70% in ADHD patients
compared to healthy volunteers (Dougherty et al., 1999).
Furthermore, reduced dopamine activity has been reported
in striatal areas of ADHD patients (Volkow et al., 2007).
Also, alterations in the dopamine receptor D1 mediated
neurotransmission in specific brain regions have been described
in animal models of ADHD, such as the spontaneously
hypertensive rats (SHR; Russell et al., 1995; Ohno et al., 2012).
Symptoms observed in ADHD patients include inattention,
hyperactivity and impulsivity (DSM-5) (Biederman and Faraone,
2005; Biederman, 2006). In these patients, attention deficits
positively correlate with impaired executive functions as for
example working memory (Takeuchi et al., 2013). In addition,
in SHR rats, hyperactivity has been strongly associated with
deficits in working memory, response inhibition and motor
timing (Kuntsi et al., 2006).
It is well known, that hippocampal theta rhythm underlie
working memory requiring optimal attention and awareness
processes (Hasselmo, 2005). Therefore, a number of studies
have been devoted to understand the mechanisms modulating
it. Several brain areas have been demonstrated to have different
roles as generators or modulators of the hippocampal rhythm.
Behavioral studies have shown that the MS regulate tasks that
demand attention (Brandner and Schenk, 1998; Walsh et al.,
1998;Ma et al., 2002). Moreover, the integrity of the entiremedial
and lateral septum-hippocampal network has been shown to
be critical for theta rhythmogenesis (Vertes and Kocsis, 1997;
Hasselmo, 2005; Nerad and McNaughton, 2006). In particular,
it has been established that predominantly GABAergic and
cholinergic neurons in the MS function as pacemaker for
the hippocampal theta rhythm (Lee et al., 1994; Vertes and
Kocsis, 1997; Apartis et al., 1998; Wang, 2002; Yoder and Pang,
2005).
The current treatment for ADHD is methylphenidate
(MPD; Abikoff et al., 2004). MPD inhibits dopamine re-
uptake by binding to the extracellular domain of the DAT
and, as a result, increasing dopamine (DA) and noradrenaline
(NE) concentration in the synaptic cleft (Zetterström et al.,
1988; Volkow et al., 1995). Studies using DAT knockout
mice demonstrated that dopaminergic and norepinephric
transmission mediates MPD induction of c-fos expression in
a number of brain areas (Trinh et al., 2003). Catecholamine
projections to septal area have been reported (Sánchez-Camacho
et al., 2003), moreover injection of D1 receptor agonists
in the MS have been demonstrated to induce acetylcholine
neurotransmitter increase in hippocampus (Zarrindast et al.,
2012). Furthermore, D1 and D5 activation enhances the firing
rates of medial septal neurons that provides a state with
higher probability for hippocampal theta occurrence (Fitch
et al., 2006), Thus we hypothesized that MPD could exerts
its effects improving attention processes via modulating the
septo-hippocampal circuitry. To our knowledge, up to date
no detailed studies of MPD effects on neuronal activity
within septal regions have been carried out. We measured
neuronal activity by analyzing c-fos expression, which has long
been considered as an inducible marker of neuronal activity,
particularly after acute stimulation (Curran and Morgan, 1995;
Kovács, 2008). Moreover, we wanted to compare our findings
with previous reports on MPD activity that had used c-fos
expression as measure of brain activation (Trinh et al., 2003).
In our model, we observed that low doses of MPD can induce
specifically c-fos activation in calretinin neuronal populations
within the septum, which may have important consequences
on septo-hippocampal connections, modulating hippocampal
function.
Materials and Methods
Animals and Storage Conditions
Procedures were in line with directive 86/609/EEC of the
European Community on the protection of animals used for
experimental and other scientific purposes and approved by
the ethic committee of the University of Valencia. A total
of 21 adult female Sprague-Dawley rats between 200--300 g
were used. All animals were maintained on a 12 h light
cycle provided with food and water ad libitum. The animals
were randomly divided into three differential groups according
to MPD treatment i.e., ‘‘Control’’, ‘‘MPD 1.3’’, ‘‘MPD 2.7’’
and MPD ‘‘5’’.
Drug Treatment
Methylphenidate (MPD, Rubifem, Laboratories Rubió, S.A,
Barcelona-Spain) was administered orally, mixed with orange
flavored jelly. Rats were habituated to jelly taste for three days
prior to drug administration on the fourth day. The control
group received jelly alone; whereas the MPD 1.3; MPD 2.7
and MPD 5 groups received 1.3; 2.7 and 5 mg/Kg of MPD
respectively. The equations should be inserted in editable format
from the equation editor.
Perfusion and Fixation
Animals were euthanized with an i.p. injection of sodium
pentobarbital (120 mg/Kg Eutanax, Fatro, Barcelona, Spain)
90 min after either jelly or drug administration. Rats were
transcardially-perfused with saline (0.9% NaCl, 250 ml) followed
by fixative (4% paraformaldehyde in 0.1 M PB, pH 7.4) for
30 min (∼600 ml). After perfusion, brains were removed from
skull and immersed in the same fixative for 4 h at 4◦C.
After fixation, brains were cryoprotected in 30% sucrose in
0.01 M phosphate buffered saline (PBS) pH 7.4 for 3 days.
Coronal sections (40 µm) were obtained using a freezing slide
microtome (Leica SM2010R, Heidelberg, Germany). For each
brain, 6 series of sections were collected in 30% sucrose in
0.01 M PBS. One of the series was directly used for c-fos
immunohistochemistry and the rest were frozen at −40◦C or
used for double labeling.
c-fos Immunocytochemistry and Double Labeling
Sections were rinsed 3 × 10 min in 0.05 M pH 8.0 Tris
Buffer Saline (TBS). Afterwards, sections were transferred to
a blocking solution containing 4% normal goat serum (NGS
Jackson Immunoresearch, West Grove, PA, USA), 2% bovine
serum albumin (BSA, (Sigma, St Louis Mo) and 0.1% Triton
X-100 (Sigma, St Louis Mo) in TBS for 1 h. Sections were
Frontiers in Neuroanatomy | www.frontiersin.org 2 March 2015 | Volume 9 | Article 33
García-Avilés et al. Metylphenidates activates calretinin neurons
incubated in a medium containing 1:10000 rabbit anti-cfos
(PC38 Anti-c-fos (Ab-5), EMD Millipore, Billerica, MA, USA)
in the same blocking solution for 48 h at 4◦C. After removing
the first antibody with several washes in TBS, biotinylated
secondary antibody (1:200 biotinylated donkey anti-rabbit; Cat
No. 711-065-152, Jackson Immunoresearch, West Grove, PA,
USA) was added to slides for 2 h. Sections were then rinsed
and transferred to 1:50 ABC (Vectastain-Elite, Cat No. PK-6100;
Vector Laboratories, Burlingame, CA, USA). After rinsing (2 ×
Tris-HCl) the immunolabeling was revealed as a black reaction
product by immersing the sections in 0.025% DAB, 0.08%
ammonium nickel sulfate, 0.0024% H2O2 in Tris HCl, pH 8.0.
Prior to mounting on chrome-alum gelatine-coated slides, tissue
was washed for at least 2 h in 0.01 M PBS. After air-dried, de-
hydrated in graded ethanol, cleared with xylene, tissue was finally
coverslipped with DPX (Sigma, St Louis Mo, USA).
Double labeling c-fos-TH was carried out following the same
protocol as above but using sequentially antisera c-fos, then anti-
sera against TH (1:1000 mouse anti-TH, T2928, Sigma, St Louis
Mo, USA). After c-fos labeling was developed (obtaining black
c-fos positive neurons), sections were rinsed overnight and the
next day incubated with biotinylated secondary antibody against
TH primary antibody (1:200 biotinylated goat anti-mouse; Cat
No. 711-065-152, Jackson Immunoresearch, West Grove, PA,
USA) for 2 h. The protocol was the same as the one used for
c-fos, but removing the ammonium nickel sulphate in the final
developing reaction, thus we detected TH positive fibers as a light
brown color.
For double immunofluorescence, sections were processed
as above, using 1:4000 rabbit anti c-fos, and either
1:5000 mouse anti parvalbumin (PV235, Swant, Marly
Switzerland), 1:2500 mouse anti-calretinin (6B3, Swant) or
1:5000 mouse anti calbindin-28 kD (CB300, Swant, Marly
Switzerland), and 1:500 anti ChAT (AB144, Chemicon,
International, Inc. Temecula, USA) in 2% normal donkey
serum (NDS Jackson Immunoresearch, West Grove, PA,
USA), 2% BSA in TBS Tx100 for 48 h at 4◦C. After rinsing,
sections were incubated with 1:200 donkey anti rabbit-Cy3
(711-165-152, Jackson) and 1:200 donkey anti mouse
(715-095-150, Jackson, Immunoresearch, West Grove, PA,
USA) for the combination of c-fos and calcium binding proteins
(PV, CB and CR) or 1:200 donkey anti rabbit-Cy3 (711-165-152,
Jackson, Immunoresearch, West Grove, PA, USA) and 1:200
donkey anti goat (705-545-003, Jackson, Immunoresearch,
West Grove, PA, USA) for the combination of c-fos and ChAT.
The secondary fluorescent antibodies were incubated for 2 h.
After incubation, the sections were rinsed in 0.01 M PBS
and coverslipped in fluorsave (345789, Millipore, Darmstadt,
Germany).
Image Analysis and Neuron Quantification
Images were acquired using a Nikon Eclipse E600 (Nikon, Tokyo,
Japan), equipped with a Nikon DMX-2000 camera connected to
a PC with ACT-1 acquisition software (Nikon, Tokyo, Japan).
For c-fos quantification we used the 20x objective and
measure c-fos activity as described (Perez-Villalba et al., 2005).
Briefly, using Image J software, the background of the images was
automatically removed with a rolling ball radius of 50.0 pixels,
only labeled areas of more than 12 pixels were considered to be
positive. Data was expressed as the ratio of c-fos positive area
normalized to total area analyzed, according to the morphology
of the nuclei examined (Table 1). All analyses were conducted
by an observer blind to experimental conditions. We used c-fos
positive area rather that number of c-fos positive neurons in
order to minimized automated errors.
Analyses of differences in c-fos immunoreactivity were done
using One-Way Analyses of Variance followed by post hoc
analyses (Bonfferoni test ) with probability set at α < 0.05, using
Graphpad Prism version 5 software.
Confocal immunofluoresence was imaged with a laser
confocal scan unit TCS-SP2 equipped with argon and helio-neon
laser beams attached to a Leica DMIRB inverted microscope
(Leica Microsystems). Wavelengths for Cy3 excitation was
433 nm and for emission 560--618 nm; Alexa488-labeled
antibody excitation was 488 nm and for emission was
510--570 nm. Serial 1 µm scans were obtained in the Z-plane
TABLE 1 | Septal nuclei c-fos levels at the indicated MPD doses.
Vehicle MPD MPD MPD
1.3 mg/Kg 2.7 mg/Kg 5 mg/Kg
Areas Mean ± SEM Mean ±SEM Mean ± SEM Mean ± SEM
MS/VDB 0.86 ± 0.03 0.49 ± 0.08 1.64 ± 0.29 *** ### 1.32 ± 0.10 *##
HDB 1.00 ± 0.09 0.78 ± 0.16 0.96 ± 0.17 0.99 ± 0.07
LSI 1.00 ± 0.08 1.15 ± 0.11 1.57 ± 0.52 1.17 ± 0.08
LSD 1.00 ± 0.10 0.68 ± 0.21 0.96 ± 0.19 1.07 ± 0.07
LSV 1.00 ± 0.10 1.27 ± 0.12 1.23 ± 0.27 1.08 ± 0.08
TS 0.99 ± 0.20 1.08 ± 0.28 1.09 ± 0.16 1.13 ± 0.07
SFi 1.00 ± 0.10 0.83 ± 0.25 1.01 ± 0.41 1.00 ± 0.15
Striatum 1.07 ± 0.12 1.05 ± 0.31 1.12 ± 0.23 2.18 ± 0.29 **#
Accubens 1.00 ± 0.11 0.83 ± 0.18 1.53 ± 0.26 1.16 ± 0.11
MeA 1.00 ± 0.08 0.95 ± 0.20 1.10 ± 0.33 1.01 ± 0.13
BLA 1.06 ± 0.09 1.11 ± 0.16 1.17 ± 0.25 1.44 ± 0.22
The area of c-fos positive neurons was studied as indicated in the text. Controls and drug were normalized to the average value of controls. Data was analyzed by ANOVA
followed by Bonferroni post hoc test. *p < 0.05, ** p < 0.01.
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and a maximal projection of 0.5 µm was generated with Leica
confocal software (V2.61).
For double labeled neuron quantification, total number of
CR, PV, CB and ChAT positive neurons were quantified in at
least ten different photographs from septum taken with the 20x
objective from at least three subjects. Double labeled neurons
were counted blindly to the treatment (no drug or 5 mg/Kg
MPD) and expressed as a percentage of total CR, PV, CB or
ChAT positive cells.
Results
This study aims to clarify the relationship between neural activity
in septal areas (associated to attention and arousal mechanisms)
and MPD treatment. Particularly, we were interested in doses
and way of administration relevant to human applications. Our
results emphasized the specificity of MPD treatment and the
relevance of CR neurons within septal areas. Using c-fos as a
marker, we found that MPD at low but clinically relevant doses
induces CR positive neurons activity in specific septal nuclei
controlling alertness and wakeful circuitries. These data suggest
that CR septal neurons may be a first target of the drug. In
addition, we examined areas with high TH staining, including
striatum and nucleus accumbens.
c-fos Expression in Septal Nuclei
We examined septal nuclei following the cytoarchitectonic map
proposed by Paxinos and Watson (Paxinos and Watson, 1996).
We first analyzed the effect of MPD administration within the
vertical medial septum (MS/VDB) and the horizontal diagonal
band (HDB) corresponding to anterior septal nuclei, Bregma
0.96--0.48 nm (Figure 1A). One-way ANOVA analysis followed
by Bonferroni post/hoc test revealed that MPD 2.7 and MPD 5
induced a significant increase in c-fos expression in MS/VDB,
(p < 0.0001, F(3,30) = 13.66) (Figure 1B) but not in the HDB
(p = 0.6441, F(3,31) = 0.5621) (Figure 1C) compared to MPD 1.3
and controls. Representative images of c-fos staining are shown
for MS/VDB (Figures 1D--G) and for HDB (Figures 1H--K), at
FIGURE 1 | c-fos expression augments with MPD treatment in MS/VDB,
but not horizontal diagonal band (HDB). Map showing the location of the
analyzed areas vertical medial septum (MS/VDB) and HBD (A). Graphs showing
the quantification of c-fos positive area expressed as the percentage of the total
area analyzed and normalized to the average of control values in MS/VDB
(B) and HDB (C). Results were analyzed with one-way ANOVA, followed by
Bonferroni post hoc test **p < 0.01). Representative images of c-fos staining in
the MS/VDB vehicle or MPD treated at the indicated dosages (D--G);
representative images of c-fos neurons in the HBD from rats treated with vehicle
or MPD at the indicated dosages (H--K). Calibration bar 100 µm.
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the indicated MPD doses. c-fos was distributed homogeneously
throughout central and lateral aspects of the MS/VDB area.
We further studied the Lateral Septum (LS) (Bregma
0.96--0.48 nm), discriminating between dorsal (LSD) inter-
mediate (LSI) and ventral parts (LSV). One-way ANOVA
analysis of c-fos data showed no significant differences within
LSD (p = 0.3205, F(3,31) = 1.223), LSI (p= 0.6726, F(3,31) = 0.5186)
(not shown) and LSV (p = 0.5211, F(3,32) = 0.7668).
Representative images are illustrated in bottom panels for LSD
and for LSV. Similarly, in the posterior septum, Triangularis
Septalis (TS) and the Septofimbrial (SFi) we did not observe
significant differences in c-fos expression; TS (p = 0.9679,
F(3,30) = 0.08468) and SFi (p = 0.9431, F(3,32) = 0.1275). These
data are summarized in Table 1.
c-fos, Amygdala
Since amygdala is involved in regulating emotional processes
and only intercalated nuclei displayed a higher concentration
of TH positive fibers, c-fos activation in this area could
be found as a negative control after MPD treatment. We
analyzed two amygdala nuclei, medial amygdala (MeA)
and basolateral amygdala (BLA), and, as expected, we
found no significant differences (data summarized in
Table 1).
c-fos, Striatum and Nucleus Accumbens
It is well accepted that MPD affects DA signaling, thus, we
set out to confirm previous results in areas with high TH
content as a control for MPD effect on neuronal activity.
We examined nucleus accumbens and striatum, Bregma
1.20--0.96 nm (Figure 2A). Statistical analysis showed that
MPD treatment did not induced significant differences in
c-fos expression within the nucleus accumbens (Figure 2B)
(p = 0.2328, F(3,31) = 1.505), whereas it had a significant effect
within the striatum (p = 0.0043, F(3,30) = 5.406) (Figure 2C).
Interestingly, we only could see this effect when using MPD
FIGURE 2 | MPD induces c-fos expression in Striatum but not nucleus
accumbens. Map showing the location of the analyzed areas (A).
Quantification of c-fos positive area represented as percentage of total area
analyzed and normalized by average value of controls, accumbens shell (B) and
striatum (C). Results analyzed with one-way ANOVA, followed by Bonferroni
post hoc test *p < 0.05. Representative images of c-fos staining in accumbens
shell (D--G) and striatum (H--K) in vehicle and MPD treated rats at the indicated
concentrations. Calibration bar 100 µm.
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FIGURE 3 | Double immunocitochemistry TH-c-fos. Representative
images illustrating double TH and c-fos staining in the dorsal part of LS
(A--C); MS/VDB (D--F); nuccleus accumbens (G--I) and striatum (J--L) in
vehicle and MPD treated rats at the indicated dosages. The vertical line
(D--F) represents the middle line of septum. Calibration bar 100 µm
(A--L).
5 mg/Kg, but not at 2.7 mg/Kg or lower dosages. Representative
pictures are shown for nucleus accumbens (Figures 2D--G) and
striatum (Figures 2H--K).
Double Labeling TH and c-fos
Confirming previous data we observed that the LSD showed
poor TH labeling (Figures 3A--C). On the other hand, TH
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staining showed an evident stripe of processes located lateral to
the MS/VDB, but not in close proximity of MPD-induced c-fos
neurons which are found more medial (control Figures 3D--F).
We show strong TH labeling in the Nucleus Accumbens
(Figures 3G--I), were c-fos expression did not augment following
MPD treatment. On the other hand, Striatum with high
TH staining MPD induced c-fos expression at 5 mg/Kg
(Figures 3J--L).
Characterization of c-fos Positive Neurons in the
Medial Septum
Although the different types of neurons may seem distributed
without a distinctive pattern in the septal area, a rough model
can be defined and corresponded to the prototype we have
previously described. Briefly, it has been described that ChAT-
positive neurons occupy lateral aspects of the MS/VDB and
concentrate in a superficial band in the HDB. On the contrary,
PV neurons populate mostly medial aspects of the MS/VDB,
whereas CR and CB neurons concentrate dorsal and laterally in
areas of the MS/VDB devoid of PV-positive neurons (Olucha-
Bordonau et al., 2012).
To determine what kind of septal neurons were activated
by acute MPD treatment, double immunofluorescence with
c-fos antibody and different neuronal markers was carried out
in both control and 5 MPD-treated rats. Quantification of at
least 20 confocal images per sample of double staining from
control and MPD treated rats, indicated that in basal conditions
approximately 28.1± 3.9%, n = 4 of the CR-positive neurons co-
labeled with c-fos and this percentage increased to 40.5 ± 3.1%,
n = 4 after MPD treatment. On the other hand, the percentage
of double labeling of c-fos with CB (14.6 ± 2.1, n = 3 basal;
16.1 ± 3.70, n = 4 MPD); PV (3.9 ± 1.7 basal; 3.4 ± 0.5,
n = 4 MPD) and ChAT (2.1 ± 0.9%, n = 4 basal; 4.0 ± 1.1%,
n = 4 MPD) did not change significantly with MPD treatment
(Figure 4). Student t-test, p = 0.04. These results suggest that low
doses of MPD targets mostly CR neurons in the MS/VDB area.
Representative confocal immunofluorescence images of c-fos
neurons from 5MPD treated rats within the MS/VDB are shown
(Figure 5). ChAT positive neurons (Figure 5A) occupy and area
with some overlapping with c-fos positive neurons (Figure 5B),
but little co-localization was observed (Figure 5C). Insets show
the staining at higher magnification to demonstrate the labeling
of single neurons. On the other hand, PV labeled neurons
(Figure 5D) lay in central aspects of MS with little overlapping
area with c-fos labeled cells (Figure 5E) and merged (Figure 5F).
Similarly to ChAT neurons, CB (Figure 5G) and CR (Figure 5J)
occupy more lateral aspects of the MS overlapping with c-fos
positive area (Figures 5H,K). Representative images of merged
photographs are shown (Figures 5I,L). High magnification
representative images of co-labeled cells are shown in the
insets.
Discussion
In this paper we report an increase of c-fos expression specifically
in calretinin neurons within the MS/VDB nuclei in the rat brain
FIGURE 4 | Quantification of double immunofluorescence. The number
of double labeled neurons in the MS/VBD was expressed as percentage of
total CR, CB, PV or ChAT positive neurons. Five to ten photographs were
taken from at least three different subjects of control and 5 MPD groups.
after MPD oral intake. MPD is a commonly prescribed drug for
children with attention deficit disorder.
The drug doses and the pathway for drug administration
are important factors to be taken into account when trying
to understand physiological mechanisms of treatments used in
human therapies studying animal models (Clark et al., 2007).
Typically, given the existing differences in metabolism between
rodents and humans, higher doses of different drugs (approx.
3-fold) are required to achieve blood levels in rats within the
range found in humans (Gatley et al., 1999; Gerasimov et al.,
2000). Children are typically treated with 0.25--1 mg/kg oral
doses of MPD, yielding peak plasma MPD levels in the range of
8--40 ng/ml (Wargin et al., 1983; Swanson and Volkow, 2002).
Studies in the adult rat showed that 0.5, 2, and 3.5 mg/kg oral
administration results in peak plasma MPD concentrations of 2,
36, and 62 ng/ml, respectively (Aoyama et al., 1990). Similarly,
Chase et al observed serum MPD levels of approximately 30,
150, and 390 ng/ml when administering 2.5, 5, and 10 mg/kg
of oral MPD (Kuczenski and Segal, 2002; Bakhtiar and Tse,
2003; Chase et al., 2005). In addition, intraperitoneally or
intraventricularly administered drugs are absorbed more rapidly
and elicits stronger effects than oral treatments. Thus, MPD
injected intraperitoneally (Schenk and Izenwasser, 2002) even at
‘‘clinically relevant’’ doses (2--5 mg/kg), yielded high serum levels
(114--269 ng/ml), far exceeding clinical relevance (Gerasimov
et al., 2000; Brandon et al., 2001; Schenk and Izenwasser,
2002).
Taken all this information together we considered the use
of 1.3, 2.7, and 5 mg/Kg in order to be in the lower, but
clinically relevant choice of MPD administration. Additionally,
handling and administration through a plastic pipette mixture
with jelly eliminate the stress produced by holding the rat and
shouting with a needle. Previous studies have developed similar
methods to orally administer drugs without the need of restraint,
eliminating stress-induced c-fos activation that potentially could
mask MPD-induced effects (Chase et al., 2005, 2007).
With this strategy, acute MPD (5 mg/kg; oral) has been
reported to significantly increase extracellular dopamine levels
in the nucleus accumbens and intensify locomotor activity
(Chase et al., 2005). Moreover, it has been found that oral
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FIGURE 5 | Confocal images of double immunofluorescence.
Low magnification captures immunofluorescence of a representative
case MPD 5 mg/Kg showing different areas occupied by ChAT
(green) (A); PV (green) (D); CB (G); and CR (J). c-fos positive
neurons (red) (B,E,H,K); and merged (C,F,I,L). Calibration bar
100 µm (A--I) and 50 µm (J--L). High magnification of the double
immunofluorescences was used for quantification and are
represented in the insets. Calibration bar 50 µm.
7.5 mg/Kg MPD treatment augmented c-fos positive neurons
in the striatum (Allen et al., 2010). Consistently, we observed
an increase in c-fos expression within the striatum when
administering 5 mg/Kg (but not at lower doses). Interestingly
in our hands we found no effect within the nucleus accumbens.
Furthermore, behavior effects have been reported with acute and
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orally given MPD (3 mg/Kg), improving learning and memory
tasks in juvenile rats (Zhu et al., 2007). These results could be
in accordance with our findings concerning c-fos expression
in the MS/VDB when using 2.7 MPD. Lower doses MPD
2 mg/kg; (oral) has been proven to be ineffective (Gerasimov
et al., 2000). Similarly, we found no changes when using
1.3 MPD.
MS has been mostly viewed as the source for subpallial
input to the hippocampus (Risold, 2004). In addition, some
tracing studies highlight the role of the MS as the source for
descending projections targeting different hypothalamic and
tegmental nuclei that, in turn, project back to the septum and
hippocampus (Leranth et al., 1999; Sánchez-Pérez et al., 2015).
On the other hand, the projections from the HDB target the
amygdala, piriform cortex and olfactory bulbs (Swanson and
Cowan, 1979). Thus, we could conclude that any alteration over
the MS region will have effects in cognitive aspects rather than
emotional ones, which would be more related to HDB activity.
Clinical effects of MPD are reported to improve awareness,
in fact it is the current prescription for children with attention
deficit disorders. Attention and awareness has been documented
to depend on hippocampal rhythm, which is, in turn, modulated
by septal-hippocampal circuitries (Bland and Oddie, 2001). A
large body of evidence have demonstrated that the MS plays
a central role in hippocampal function as measured by theta
rhythm (Hajós et al., 2003, 2008; Krause et al., 2003; Berridge and
Devilbiss, 2011). Moreover, manipulation of DA transmission
in the septal area affects hippocampal theta synchronicity
(Miura et al., 1987; Fitch et al., 2006), and a specific role
for MS/VDB cells expressing D1/5 receptor in theta rhythm
modulation has been observed (Fitch et al., 2006). Additionally,
injection of D1 agonists in the MS has been reported to
increase acetylcholine levels in the hippocampus (Zarrindast
et al., 2012).
We have found that low levels of orally administered
MPD increases neuronal activity, as measured by c-fos protein
expression, specifically in the MS (at 2.7 mg/Kg doses) and at in
the striatum (at 5 mg/Kg doses). c-fos has long been recognized
as a marker for neuronal activation (Curran and Morgan, 1995;
Kovács, 2008). Moreover, previous work had reported c-fos
induction in different brain areas in response to high doses of
intraperitoneally administered MPD (Trinh et al., 2003).
The MS/VDB is composed of different type of neurons;
ChAT, PV, CB28kD and CR neurons (Kiss et al., 1997). ChAT
and PV are hippocampal projecting cholinergic and GABAergic
neurons (Freund, 1989). Only around 10% of CB28kD and
CR neurons are GABAergic, while a major proportion, (40%
approximately of CB28kD neurons and around 80% of CR
neurons are glutamatergic (Gritti et al., 2003). It has been
proposed that intrinsic septal glutamatergic projection may
be involved in generation and modulation of hippocampal
theta rhythm through projections to PV (Hajszan et al., 2004)
and ChAT (Wu et al., 2004) septo-hippocampal neurons. In
addition, CR neurons are the source of descending projections
to hypothalamic (supramammillary) (Leranth et al., 1999) and
tegmental (nucleus incertus) (Sánchez-Pérez et al., 2015) areas
that are also involved in theta rhythm generation.
In order to elucidate the phenotype of neurons affected by
MPD acute treatment, we labeled the cells with diverse neuronal
markers and analyzed the double staining. We show that the
percentage of CR positive neurons that co-localized with c-fos
increased significantly after MPD treatment, indicating that in
our conditions, MPD may target specifically CR neurons in the
MS/VHD. Our data would be in accordance to the reported
sensitivity of CR-GABAergic neurons to MPD treatment in
the tail of the ventral tegmental area (VTA; Kaufling et al.,
2010). Although there is no detailed description of DA receptors
expression in CR septal neurons, striatal CR interneurons have
been reported to express low to moderate levels of the D5
receptor (D1 subtype of DA receptors), whereas higher levels
of D5 expression are found in PV and ChAT neurons (Rivera
et al., 2002). On the other hand, β1 and β2 adrenergic receptors
have been found in several subtypes of GABAergic, including
CR, CB and PV, neurons in prefronal cortex (Liu et al., 2014).
Interestingly, our current findings clearly support an action
of low and clinical relevant doses of MPD specifically in CR
neurons, whereas not affecting other subtypes of GABAergic
neurons (PV, CB) nor cholinergic positive neurons within the
MS/VDB.
Given the role of MPD as DAT inhibitor, this drug could
be acting by increasing catecholamine transmission in the
MS/VDB as it has been already reported in prefrontal cortex
(Berridge et al., 2006). Interestingly, we observed few TH
positive fibers inside the MS, and these results are consistent
with other previously published (Lindvall and Stenevi, 1978;
Fitch et al., 2006). However, DA neurotransmission can also
occur by volume diffusion, meaning that it may not require
synaptic proximity to elicit its action (Cragg et al., 2001). On
FIGURE 6 | Proposed mechanism for MPD role in attention. Taking
together the present data and others we propose that MPD may inhibit
dopamine re-uptake leaving more dopamine in the extracellular space (1). This
extra amount of dopamine will more effectively activate D1/5 receptors in the
medial septal neurons. Specifically, the activation of CR neurons in this area
will potentiate the effect on intrinsic connections inside the medial septum and
descending projections over areas projecting to hippocampus (2). Then
subcortical projections may enhance theta rhythm and consequently attention
mechanisms (3).
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the other hand, we cannot completely rule out a putative MPD
effect on other neurotransmitters; for instance, MPD can induce
histamine release in rat prefrontal cortex (Horner et al., 2007).
Taking together all these data together with our own results,
it is possible that MPD by inhibiting dopamine reuptake
directly activates CR positive neurons within the MS/VDB. The
increase of dopamine in the extracellular space may activate
D1/5 receptors inducing potentiation of intrinsic GABAergic
and descending glutamate projections to areas involved in
theta activation (Figure 6). The action of MPD modulating
awareness processes and supporting cognitive function is largely
accepted, therefore, our data showing a specific effect of MPD
on medial septal CR neurons, highlights the importance of this
type of neurons in attention processes underlying hippocampal-
dependent behavior.
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